M&A
M&A: Fundamental to Pharma Industry Growth
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-20-NI-002Mar 20, 2020
Nice Insight Overview
Understanding a Dynamic Industry Through Mergers and Acquisitions
Nigel Walker
Nice Insight
PAP-Q1-20-NI-001Mar 19, 2020
Pharmaceutics Know-How
Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO
Kurt R. Nielsen, Ph.D.
Pii
PAP-Q1-20-CL-001Mar 19, 2020
AAV Vector Production
Challenges to Process Validation for Viral Vectors
Kyle Zingaro, Ph.D.; Deborah Mar Begos; Todd Miller
Thermo Fisher Scientific
PAP-Q1-20-CL-002Mar 19, 2020
CDMO Leadership
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q1-20-CL-003Mar 19, 2020
Excipients
New Mannitol Formulations Are a Gem of a Collection
Graeme MacLeod; Bill McCarthy
SPI Pharma
PAP-Q1-20-CL-004Mar 19, 2020
Virtual Panel
Leveraging a Biomanufacturing Legacy to Support New Business
Grifols Recombinant Protein CDMO
PAP-Q1-20-CL-005Mar 19, 2020
Microbiome
Reflections on a 10-Year Journey in the Microbiome
Aaron B. Cowley, Ph.D.
Arranta Bio
PAP-Q1-20-CL-006Mar 19, 2020
Business Models
CDMO Services Designed to Support Evolving Pharma Business Models
Patrice Martin
Servier
PAP-Q1-20-CL-007Mar 19, 2020
Small-Volume Manufacturing
Benefits of Integrated Small-Volume Manufacturing Capabilities
James J. Springer, Ph.D.; Mitch Kenyon; Tyler Kerr; James Goodwin
Albemarle Fine Chemistry Services
PAP-Q1-20-CL-008Mar 19, 2020
Tracking and Visibility
Proprietary Tracking and Visibility Tools Ensure Secure Transportation
Marc Boyle
Boyle Transportation
PAP-Q1-20-CL-009Mar 19, 2020
Continuous Improvement
The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing
Antonio A. Gomez
Grifols
PAP-Q1-20-CL-010Mar 19, 2020
Drug Development
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
Jonathan Reis, Ph.D.
PAP-Q1-20-CL-011Mar 19, 2020
Amorphous Solid Dispersion
Small-Scale Screening Technology for Amorphous Solid Dispersion Development
Daniel Treffer, Ph.D.
MeltPrep
PAP-Q1-20-CL-012Mar 19, 2020
Bioinformatics
Leveraging Bioinformatics for Nontraditional Drug Discovery
Ben Zeskind, Ph.D
Immuneering Corporation
PAP-Q1-20-CL-013Mar 19, 2020
RNA Biomarkers
RNA Biomarkers for Early Lung Cancer Diagnosis
Ron Andrews
OncoCyte
PAP-Q1-20-CL-014Mar 19, 2020
Immune Therapies
An R&D Engine for Novel Immune Therapies
Alexis Peyroles
OSE Immunotherapeutics
PAP-Q1-20-CL-015Mar 19, 2020
In Conversation
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
Emilie Branch; Gary Lord; Dago Caceres; Patrick Soon-Shiong, M.D.
Pharma's Almanac
PAP-Q1-20-CL-016Mar 19, 2020
Complex Manufacturing
Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation
Scott Doncaster; Clarke MacDonald
BIOVECTRA
PAP-Q1-20-CL-017Mar 19, 2020
Cancer Screening
Innovating to Increase Adherence for Colon Cancer Screening
Alex Ovadia
Check-Cap
PAP-Q1-20-CL-018Mar 19, 2020